started · updated
CVM mandates Centaurus Capital to launch tender offer for Oncoclínicas
The Brazilian Securities and Exchange Commission (CVM) has unanimously decided that Centaurus Capital must launch a public tender offer (OPA) for shares of Oncoclínicas. This decision reverses a previous stance by the CVM's technical department, which had argued against the necessity of the offer.
The dispute centers on a 'poison pill' clause in Oncoclínicas' bylaws, which mandates a tender offer if an investor's stake exceeds 15%. Minority shareholders, led by Latache Capital, argue that a 2024 corporate reorganization involving Goldman Sachs funds effectively triggered this clause by concentrating a 31.83% stake into the Josephina III fund, a vehicle linked to Centaurus.
Centaurus maintains that its economic interest in the company has existed since before the IPO and that the reorganization was merely a change in the structure of ownership rather than a new acquisition. While the CVM board ruled in favor of the minority shareholders, the legal battle continues. Centaurus has initiated arbitration through the B3 Arbitration Chamber, and the Brazilian Association of Investment, Credit, and Consumption (Abraicc) intends to file a lawsuit to enforce the offer.
Entities
CVM · Centaurus Capital · Comissão de Valores Mobiliários · Goldman Sachs · Latache Capital · Oncoclínicas
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] The CVM board unanimously decided that Centaurus must conduct a public tender offer (OPA) for Oncoclínicas shares. guiadoinvestidor.com.br · veja.abril.com.br
- [○ 1 SOURCE] The Brazilian Association of Investment, Credit, and Consumption (Abraicc) plans to file a legal action to compel the tender offer. oglobo.globo.com
- [○ 1 SOURCE] Oncoclínicas has a total liability of R$ 5.1 billion.
- [● 3 SOURCES] The CVM board reversed the previous understanding held by its technical department. guiadoinvestidor.com.br · veja.abril.com.br
- [● 2 SOURCES] Centaurus has initiated arbitration proceedings through the B3 Arbitration Chamber. guiadoinvestidor.com.br · oglobo.globo.com
- [● 2 SOURCES] The transaction is estimated by the market to be worth approximately R$ 6.5 billion. guiadoinvestidor.com.br · oglobo.globo.com
- [○ 1 SOURCE] Latache Capital argues that the 2024 corporate reorganization triggered the mandatory tender offer requirement. guiadoinvestidor.com.br
- [● 2 SOURCES] The company's bylaws include a 'poison pill' clause requiring a tender offer if an investor exceeds a 15% ownership stake. noticias.uol.com.br · veja.abril.com.br